STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: Biotage (STO:BIOTA): Net sales amounted to 361.9 (382.9) MSEK in the period January – September 2007 and to 111.9 (133.9) MSEK in the third quarter. At comparable exchange rates and excluding the Chem Dev product area, which is being closed down, sales increased by 1% in the nine month period and decreased by 12% in the third quarter. The operating result for the first nine months 2007 amounted to 27.6 (-2.9) MSEK. The operating result for the third quarter amounted to 9.3 (11.4) MSEK. In the first nine months 2007 net profit amounted to 56.5 (-8.2) MSEK and earnings per share to 0.64 (-0.09) SEK. In the third quarter profit after tax amounted to 11.2 (8.6) MSEK and earnings per share to 0.13 (0.10) SEK. The cash flow from operating activities amounted to 21.2 (11.9) MSEK in the first nine months and to 22.9 (17.4) MSEK in the third quarter.
